Trial NCT02952989

View at ClinicalTrials.gov 
Org. Study IDs: SGN2FF-001

Last trial update was posted on 2019-07-19

MeSH Interventions

Pembrolizumab

MeSH Conditions

Adenocarcinoma Breast Neoplasms Carcinoma Carcinoma, Non-Small-Cell Lung Carcinoma, Renal Cell Carcinoma, Squamous Cell Colorectal Neoplasms Neoplasms Squamous Cell Carcinoma of Head and Neck Urinary Bladder Neoplasms

Other Conditions

Carcinoma, Squamous Cell of Head and Neck Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma Urinary Bladder Neoplasm

Stopping Reasons

Due to overall benefit/risk profile

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID